Impact on quality of life after an intensive care unit stay
Official title: Experience of Staying in Intensive Care and Impact on Quality of Life
Run by University Hospital, Strasbourg, France · NCT07339891 · Data updated 2026-11-12
This project will see if adults who spend more than 48 hours in intensive care develop post‑traumatic stress that affects their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Months and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | June 23, 2025 |
| Main results expected | June 2026 |
| Study ends | June 23, 2026 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT07339891 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) who had an unplanned ICU stay longer than 48 hours and can read and complete questionnaires in French are the ideal candidates.
✕Probably not a fit
Patients admitted after scheduled surgery, those readmitted within 30 days, individuals under guardianship, or those unable to complete French questionnaires are unlikely to be eligible and would not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will measure patients' experiences during an intensive care unit (ICU) stay and track their quality of life after discharge. Adults who stayed in ICU more than 48 hours will be invited to complete questionnaires about memories of the stay, post‑traumatic stress symptoms, and overall quality of life. The study excludes planned surgical admissions, recent ICU readmissions, patients under legal guardianship, and those unable to complete or understand French questionnaires. The work is conducted at the surgical ICU of CHU de Strasbourg and does not involve any clinical interventions.
Why it matters
Potential benefit: If successful, the results could identify modifiable aspects of ICU care (for example diaries or improved communication) that reduce post‑traumatic stress and improve quality of life after discharge.
How similar studies have gone: Previous qualitative and quantitative studies—including work on ICU logbooks/diaries—have shown links to reduced PTSD incidence, so similar approaches have shown promise.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient (≥ 18 years) * Stay in intensive care \> 48 hours Exclusion Criteria: * Admission to intensive care following scheduled surgery. * Readmission to intensive care (previous admission within the 30 days prior). * Patient under legal guardianship * Inability to complete a questionnaire * Poor reading and/or speaking comprehension of French * Patient under guardianship or conservatorship.
Where it's running
-
Service de Réanimation Chirurgicale - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Coralie PAUZET, MD
- Email: coralie.pauzet@chru-strasbourg.fr
- Phone: 33 3 69 55 05 57
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Anger, Social Thinking, and PTSD in French Veterans
This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.
-
TSND-201 treatment for PTSD in adults
This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.
-
Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD
This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.
-
SEE FAR CBT for Adults With PTSD
This 12-week, one-on-one SEE FAR CBT program tests a trauma-focused therapy to see if PTSD symptoms improve in adults 18 and older.
-
Brief SEE FAR CBT: a short, focused therapy for adults with PTSD
A 6-session Brief SEE FAR CBT treatment is tested against usual dynamic psychotherapy for adults with PTSD to see if it reduces symptoms.
-
MDMA Therapy for PTSD in Veterans
This phase 2 study tests a fixed 120 mg dose of MDMA, followed by a 60 mg supplemental dose, plus therapy, to see if it helps adults who are veterans with PTSD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.